Skip to main content
Clinical Trials/CTRI/2021/05/033724
CTRI/2021/05/033724
Completed
未知

Role of Maternal serum placental growth factor and hematological parameters at 11â??14weeks of gestation to predict gestational diabetes mellitus: A Prospective observational study

Dr Mounika Koduri0 sites320 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O244- Gestational diabetes mellitus
Sponsor
Dr Mounika Koduri
Enrollment
320
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 1, 2022
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Dr Mounika Koduri

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria: Singleton pregnancies at 11\-14 weeks of gestation, at the time of combined
  • screening for aneuploidy and preeclampsia by ultrasound scan and maternal serum
  • biochemistry, who come to obstetrics and gynaecology OPD of Kasturba Hospital Manipal for
  • regular ANC checkup.

Exclusion Criteria

  • Exclusion Criteria:
  • 1\)Women who have been diagnosed with hypertensive disorders in pregnancy
  • 2\)Previous pregnancy complicated with Gestational diabetes mellitus (GDM)
  • 3\)Pre\-existing diabetes mellitus detected by HbA1C \>6
  • 4\)Pregnancies with chromosomal abnormal fetuses or structural defects at 11\-14 weeks
  • 5\)Pregnancies diagnosed with severe Early onset IUGR
  • 6\)Those who are not willing to participate in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials